Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease

NCT03865407 is registered in ClinicalTrials.gov with Virginia Commonwealth University as lead sponsor.

NCT NCT03865407
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03865407 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Uric Acid Reduction as a Novel Treatment for Pediatric Chronic Kidney Disease
Lead sponsor
Virginia Commonwealth University
Phase
Phase 2
Overall status
Terminated
Start date
March 10, 2019
Completion date
October 7, 2020
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney diseases, hyperuricemia